CircuLite

CircuLite is a cardiovascular device company that is transforming heart failure treatment with the development of minimally-invasive micro-pumps for long-term partial circulatory support (PCS). By enabling a proactive and lower-risk treatment approach by supplementing a patient's native pumping capacity, CircuLite has the potential to improve the quality of life for millions of chronic heart failure patients and their families. The company's proprietary micro-pump platform enables its PCS devices to be so small that they can be implanted superficially in a pacemaker-like pocket with endovascular or minimally-invasive surgical techniques.

CircuLite headquartered in United States, North America, operates in the Health Care, Medical Device, Hospital sector. The company focuses on Health Care and has secured $6.9B in funding across 72 round(s). With a team of 251-500 employees, CircuLite is actively contributing to advancements in Health Care. Their latest funding round, Series C - CircuLite, raised $32.5M. Discover more about their projects, partnerships, and impact on our platform.